Amagma Therapeutics

About:

Amagma Therapeutics specializes in the discovery and development of antibody therapeutics against inflammatory diseases.

Website: https://amagmatx.com/

Top Investors: Polaris Partners, Magnetic Ventures

Description:

Amagma Therapeutics is a biotechnology company that specializes in the discovery and development of antibody therapeutics against inflammatory diseases. Its technology overactive extracellular proteases trigger tissue damage that can sustain broad inflammatory responses. The company was founded in 2019 and headquartered in Waltham, Massachusetts.